ChromaDex Corp. (CDXC)

[Milarepa]

Not quite the same. This year they said (past tense) we listed on NASDAQ, we demonstrated safety and efficacy, and we received GRAS status. That is very significant progress, and basically amounts to executing their plan. Results would have been better if Elysium didn't freak out, but there was still plenty of top-line growth. They say their plan, they execute their plan. I have no complaints.

I agree with ChromaDex that nothing is going to get them into the tornado of mainstream acceptance besides human studies, and I can't think of anything ChromaDex could do to speed that up, so no complaints there, either.

The only tension I am getting is between message A: "Pedal to the Metal, divert al power to Niagen, which is why we are letting PteroPure and AnthoPurpleWhatever idle," and message B: "We just built a new lab and we have a robust business model built on a pipeline of future products." Both statements can be true, but ChromaDex hasn't really told us how their eggs are allocated between these two baskets or why. Nonetheless, I do not see anything particularly troubling.